0001802369-21-000004.txt : 20210817
0001802369-21-000004.hdr.sgml : 20210817
20210817155006
ACCESSION NUMBER: 0001802369-21-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210817
DATE AS OF CHANGE: 20210817
EFFECTIVENESS DATE: 20210817
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADARx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001802369
IRS NUMBER: 844145188
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-410307
FILM NUMBER: 211182681
BUSINESS ADDRESS:
STREET 1: 5871 OBERLIN DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-283-9472
MAIL ADDRESS:
STREET 1: 5871 OBERLIN DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
D
1
primary_doc.xml
X0708
D
LIVE
0001802369
ADARx Pharmaceuticals, Inc.
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO
CA
CALIFORNIA
92121
858-283-9472
DELAWARE
None
None
Corporation
true
2019
Zhen
Li
c/o ADARx Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Rui
Zhu
c/o ADARx Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego
CA
CALIFORNIA
92121
Executive Officer
Carl
Gordon
c/o ADARx Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego
CA
CALIFORNIA
92121
Director
Erez
Chimovits
c/o ADARx Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego
CA
CALIFORNIA
92121
Director
Sheila
Gujrathi
c/o ADARx Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego
CA
CALIFORNIA
92121
Director
Xiong
Zhang
c/o ADARx Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego
CA
CALIFORNIA
92121
Director
Simeon
George
c/o ADARx Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego
CA
CALIFORNIA
92121
Director
Yuan
Sun
c/o ADARx Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego
CA
CALIFORNIA
92121
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-07-30
false
true
false
0
74999996
74999996
0
false
6
0
0
0
false
ADARx Pharmaceuticals, Inc.
/z/ Zhen Li
Zhen Li
President and Chief Executive Officer
2021-08-17